NYSE · Drug Manufacturers - Specialty & Generic

Hims Hers Health Inc (HIMS)

$27.51 +0.26%
Add alert
43 In band Daily RSI (14) · 11 Sep 2026

Moving averages

SMA 50$31.04-11.37%
SMA 200$28.30-2.79%
EMA 20$29.06-5.33%

Company profile

Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers with licensed healthcare professionals. The company is headquartered in San Francisco, California.

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Market cap$6.51B
P/E ratioNone
EPS$-0.63
Beta2.412
Dividend yield0.00%
52-week high$65.30
52-week low$13.74

Insider transactions

ExecutiveTitleActionSharesDate
BOUGHTON, SOLEILChief Legal OfficerSell3,4582026-09-02
DUDUM, ANDREWDirector, Chief Executive Officer, 10% OwnerSell977,5662026-08-27
DUDUM, ANDREWDirector, Chief Executive Officer, 10% OwnerSell463,2892026-08-25
Continue with Google
Unlock insider transactions

Latest news

HIMS INVESTOR DEADLINE: Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Before November 2, 2026 Deadline, Robbins Geller Rudman & Dowd LLP Announces
Bearish The Daily Tribune News 4 days ago
HIMS & HERS HEALTH, INC. INVESTORS WITH LOSSES HAVE UNTIL NOVEMBER 2, 2026 TO JOIN SECURITIES CLASS ACTION – Bernstein Liebhard LLP Announces Deadline
Bearish GlobeNewswire 4 days ago
Hims & Hers Health, Inc. Securities Fraud Class Action Result of Deceptive Privacy and Billing Practices and Over 14% Stock Decline - Investors may Contact Lewis Kahn, Esq., at Kahn Swick & Foti, LLC
Bearish ACCESS Newswire 6 days ago

Earnings call transcript

Q2 2026

Hello, everyone. Thank you for joining us and welcome to the Hims & Hers Health Second Quarter 2026 earnings call. I will now turn the conference over to Bill Newby, Director of Investor Relations. Bill, please go ahead.…

Continue with Google
Unlock the earnings call transcript

Options chain

TypeStrikeExpiryVolumeOpen interest
Call$29.002026-09-185,0731,706
Call$28.002026-09-184,1931,965
Call$28.002026-09-113,0661,830
Continue with Google
Unlock the options chain

Similar stocks in Drug Manufacturers - Specialty & Generic

CGC Canopy Growth Corporation RSI 36 BFRI Biofrontera Inc RSI 60 TLRY Tilray Brands Inc - Class 2 RSI 33 LNTH Lantheus Holdings Inc RSI 43 ACB Aurora Cannabis Inc RSI 53 BCRX Biocryst Pharmaceuticals Inc RSI 30 INM InMed Pharmaceuticals Inc RSI 37 ORGO Organogenesis Holdings Inc - Class A RSI 29 ZTS Zoetis Inc - Class A RSI 57 AQST Aquestive Therapeutics Inc RSI 52
Free forever

RSI alerts for HIMS

Get an email the moment Hims Hers Health Inc crosses into oversold or overbought territory. Nothing else, ever.

Add alert

Data last updated 14 September 2026 at 12:05 AM EDT